Cargando…

Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab

Vedolizumab (VDZ) has been approved for the treatment of inflammatory bowel diseases (IBDs) in patients aged ≥18 years. We report a case of a pediatric patient with Crohn disease (CD) who was successfully treated with VDZ. A 16-year-old female developed severe active pulmonary tuberculosis (TB) duri...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Sujin, Choi, Bong Seok, Choe, Byung-Ho, Kang, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yeungnam University College of Medicine 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225501/
https://www.ncbi.nlm.nih.gov/pubmed/33601494
http://dx.doi.org/10.12701/yujm.2020.00878